Figure 5.
Treatment initiation and continuation of sodium–glucose cotransporter 2 inhibitors (SGLT2i) in patients admitted for acute decompensated heart failure.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.